Editas Medicine Stock (NASDAQ: EDIT) stock price, news, charts, stock research, profile.
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Other companies in Editas Medicine’s space includes: Precigen (NASDAQ:PGEN), PepGen (NASDAQ:PEPG), Kyverna Therapeutics (NASDAQ:KYTX), TScan Therapeutics (NASDAQ:TCRX) and aTyr Pharma (NASDAQ:ATYR).
Editas Medicine has a consensus price target of $12.24.
The stock price for Editas Medicine (NASDAQ: EDIT) is $2.9001 last updated October 31, 2024 at 6:26 PM EDT.
There are no upcoming dividends for Editas Medicine.
Editas Medicine’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.